BRAI3N stands for Brain Research center for Advanced, Innovative, Interdisciplinary and International Neuromodulation.
BRAI3N follows the philosophy of Albert Einstein: "The grand aim of all science is to cover the greatest number of empirical facts by logical deduction from the smallest number of hypotheses or axioms".
BRAI3N aims to develop new neuromodulation treatments by combining the common neurophysiological mechanisms of diseases, such as the 'thalamocortical dysrhythmia' (tinnitus, pain, Parkinson, depression, epilepsy) and the 'reward deficiency syndromes' (obesity, addiction, obsessive compulsive disorder, ADHD, Autism, Tourette and other "tic" syndromes, personality disorders).
BRAI3N is a multidisciplinary and international collaboration between doctors from different disciplines, specialists in neuromodulation, (neuro) psychologists, audiologists, physiotherapists and neuroscientists.
Internationally we work closely together with labs in Dallas (University of Texas at Dallas, Lab for Clinical and Integrative Neuroscience), New Zealand (University of Otago) and South Korea (Seoul National University Bundang Hospital).
To complement each other, each partner focuses on a specific part of the joint scientific research.
As a result, new scientific insights can be applied clinically and new clinical insights can also be scientifically tested. This way we can quickly apply new, scientifically founded treatment protocols.